Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Network measures predict neuropsychological outcome after brain injury

  • Evidence of genetic link to PTSD in soldiers exposed to childhood trauma

  • Size at birth affects risk of adolescent mental health disorders

  • First blood test to diagnose depression in adults

  • Smart teens rub off on teammates, study shows

  • Lack of facial expression leads to perceptions of unhappiness, new research shows

  • Entrepreneurs aren't overconfident gamblers, researchers say

  • Babies learn words differently as they age, researcher finds

  • Fighting parents hurt children's ability to recognize and regulate emotions

  • Power isn't enough: Study reveals missing link for effective leadership

  •